Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Blood

Volumn 98, Issue 10, 2001, Pages 3066-3073

  Stahnke, Karsten ^a,b   Fulda, Simone ^a,b   Friesen, Claudia ^a,b   Strauß, Gudrun ^a,b   Debatin, Klaus Michael ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CAMPTOTHECIN; CASPASE 3; CASPASE 8; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; MITOMYCIN; PREDNISOLONE; PROTEIN BAX; PROTEIN P53; VINCRISTINE; VINDESINE;

ADOLESCENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME INHIBITION; HAIR LOSS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SOLID TUMOR;

EID: 0035892135     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.10.3066     Document Type: Article

References (44)

1. Mackall C-L, Fleisher T-A, Brown M-R, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994;84:2221-2228.
2. Mackall C-L, Hakim F-T, Gress R-E. Restoration of T cell homeostasis after T cell depletion. Semin Immunol. 1997;9:339-346.
3. Ashkenazi A, Dixit V-M. Death receptors: signaling and modulation. Science. 1998;281:1305-1308.
4. Adams J-M, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
5. Kroemer G, Reed J-C. Mitochondrial control of cell death. Nat Med. 2000;6:513-519.
6. Thornberry N-A, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.
7. Dive C, Evans C-A, Whetton A-D. Induction of apoptosis-new targets for cancer chemotherapy. Cancer Biol. 1992;3:417-427.
8. Hannun Y-A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 1997;89:1845-1853.
9. Los M, Herr I, Friesen C, Fulda S, Schulze Osthoff K, Debatin K-M. Cross resistance of CD95 and drug induced apoptosis as a consequence of deficient activation of caspases (ICE/CED 3 proteases). Blood. 1997;90:3118-3129.
10. Sun X-M, MacFarlane M, Zhuang J, Wolf B-B, Green D-R, Cohen G-M. Distinct caspase cascades are initiated in receptor mediated and chemical induced apoptosis. J Biol Chem. 1999;274:5053-5060.
11. Scaffidi C, Medema J-P, Krammer P-H, Peter M-E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem. 1997;272:26953-26958.
12. Friesen C, Herr I, Krammer P-H, Debatin K-M. Involvement of the CD95 (APO 1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med. 1996;2:574-577.
13. Müller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO 1/Fas) receptor/ligand system and involves activation of wild type p53. J Clin Invest. 1997;99:403-413.
14. Fulda S, Sieverts H, Friesen C, Herr I, Debatin K-M. The CD95 (APO 1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 1997;57:3823-3829.
15. Houghton J-A, Harwood F-G, Tillman D-M. Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc Natl Acad Sci U S A. 1997;94:8144-8149.
16. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer P-H. Autocrine T cell suicide mediated byAPO 1/Fas (CD95). Nature. 1995;373:438-441.
17. Ferrari D, Stepczynska A, Los M, Wessellborg S, Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med. 1998;188:979-984.
18. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood. 1996;88:386-401.
19. Weller M, Winter S, Schmidt C, et al. Topoisomerase I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and Bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta lapachone. Int J Cancer. 1997;73:707-714.
20. Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 1997;57:62-67.
21. Kim CN, Wang X, Huang Y, et al. Overexpression of Bcl-XL inhibits Ara C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 1997;57:3115-3120.
22. Milner J. DNA damage, p53 and anticancer therapies. Nat Med. 1995;1:879-880.
23. Levine A-J. p53, The cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
24. Miyashita T, Reed J-C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299.
25. Miyashita T, Krajewski S, Krajewska M et al. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
26. Scaffidi C, Medema J-P, Krammer P-H, Peter M-E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem. 1997;272:26953-26958.
27. Klas C, Debatin K-M, Jonker R-R, Krammer P-H. Activation interferes with the APO 1 pathway in mature human T cells. Int Immunol. 1993;5:625-630.
28. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actin cleavable interleukin 1 beta converting enzyme (ICE) family protease CPP 32 during chemotherapeutic agent induced apoptosis in ovarian carcinoma cells. Cancer Res. 1996;56:5224-5229.
29. Datta R, Banach D, Kojima H, et al. Activation of the CPP32 protease in apoptosis induced by 1 beta D arabinofuranosylcytosine and other DNA damaging agents. Blood. 1996;88:1936-1943.
30. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin K-M. Cross-resistance of CD95 and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced 3 proteases). Blood. 1997;90:3118-3129.
31. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489-495.
32. Hakim F-T, Cepeda R, Kaimei S, et al. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood. 1997;90:3789-3798.
33. Brugnoni D, Airo P, Pennacchio M, et al. Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death. Bone Marrow Transplant. 1999;23:451-457.
34. Fulda S, Friesen C, Los M, et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997;57:4956-4964.
35. Wesselborg S, Engels I-H, Rossmann E, Los M, Schulze-Osthoff K. Anticancer drugs induce caspase 8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood. 1999;93:3053-3063.
36. Marchetti P, Castedo M, Susin S-A, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155-1160.
37. Macho A, Castedo M, Marchetti P, et al. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus 1 carriers. Blood. 1995;86:2481-2487.
38. Cossarizza A, Mussini C, Mongiardo N, et al. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS. 1997;11:19-26.
39. Narita M, Shimizu S, Ito T, et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci U S A. 1998;95:14681-14686.
40. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999;399:483-487.
41. Owen-Schaub L-B, Zhang W, Cusack J-C, et al. Wild type human p53 and a temperature sensitive mutant induce Fas/APO 1 expression. Mol Cell Biol. 1995;15:3032-3040.
42. Wlodarski P, Wasik M, Ratajczak M-Z, et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood. 1998;91:2998-3006.
43. + cells recovering after chemotherapy [letter]. Blood. 1998;92:4880-4881.
44. Ferraro C, Quemeneur L, Prigent AF, Taverne C, Revillard J-P, Bonnefoy-Berard N. Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res. 2000;60:1901-1907.